推荐产品
product name
BHL-89, 98070109
生物源
human lymph (axillary)
增長模式
Suspension
染色體組型
Hyperdiploid, modal no. 47, chromosome 1 trisomy, 15 monosomy, +14q+
形態學
Lymphoblastoid
產品
Not specified
受體
sIgM,CD22,BB1,HLA-ABC,GnRH
技術
cell culture | mammalian: suitable
相關疾病
cancer
運輸包裝
dry ice
儲存溫度
−196°C
細胞系來源
Human B-type EBNA negative lymphoma
細胞系描述
The cell line BHL-89 was established from a 56 year old female patient with chronic lymphoid leukaemia (CLL). The B-cell type cells were shown to express CD9, CD22, CD71,HLA-ABC, BB1, GnRH and surface IgM. Cloning efficiency in soft agar was found to be between 20-60% and population doubling time was 48 hours. BHL-89 cells are Epstein-Barr nuclear antigen (EBNA) negative. They have been shown to be tumourigenic in immunosuppressed mice, sensitive to dibromodulcitol and resistant to the phorbol ester TPA. The cell line was found to be positive for BCL-2 protein and produces small amounts of interferon. Lymphoblastoid cells and floating aggregates. The cell line has been eradicated from mycoplasma at ECACC.
應用
B lymphoma studies, cancer treatments
培養基
RPMI1640 + 2mM Glutamine + 15% Foetal Bovine Serum (FBS).
例行更新培養
Maintain cultures between 1-5 x 100,000 cells/ml;5% CO2; 37°C
其他說明
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门